US Stock MarketDetailed Quotes

Intelligent Bio Solutions (INBS)

Watchlist
  • 4.110
  • +0.120+3.01%
Close May 14 16:00 ET
  • 4.100
  • -0.010-0.24%
Post 16:51 ET
9.83MMarket Cap-0.35P/E (TTM)

Intelligent Bio Solutions (INBS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.57%-1.57M
-19.25%-2.85M
-1.10%-9.68M
24.93%-2.21M
-12.62%-2.76M
18.97%-2.32M
-81.98%-2.39M
-29.74%-9.57M
-403.82%-2.94M
2.85%-2.45M
Net income from continuing operations
-19.05%-2.69M
-11.14%-2.99M
-4.06%-10.6M
-10.99%-3.1M
14.60%-2.55M
-14.19%-2.26M
-10.79%-2.69M
4.44%-10.19M
-4.64%-2.8M
52.98%-2.99M
Operating gains losses
----
----
----
----
----
----
----
-88.02%1.18K
----
----
Depreciation and amortization
-8.37%281.9K
0.09%303.38K
0.05%1.21M
6.43%306.17K
-9.37%296.83K
5.97%307.64K
-1.45%303.11K
25.48%1.21M
69.15%287.69K
-17.81%327.53K
Other non cash items
-77.38%11.6K
224.02%147.84K
0.52%-24.05K
-32.24%49.67K
83.32%-5.79K
138.35%51.28K
-267.99%-119.21K
89.12%-24.18K
175.46%73.3K
-268.36%-34.73K
Change In working capital
267.92%736.95K
-636.17%-576.91K
-2.69%-720.78K
157.38%304.21K
-1,827.58%-507.75K
56.40%-438.87K
-109.73%-78.37K
-989.45%-701.93K
-125.99%-530.18K
108.38%29.39K
-Change in receivables
16.22%680.06K
-15.08%-312.86K
-20,620.37%-2.86M
-2,341.33%-2.78M
-177.48%-389.51K
-12.95%585.15K
37.01%-271.88K
-102.33%-13.81K
-110.25%-114.05K
-13.15%-140.37K
-Change in inventory
1.13%37.93K
-81.84%7.04K
-29.67%142.32K
-51.90%48.27K
-86.64%17.79K
71.46%37.51K
173.06%38.75K
158.59%202.37K
137.10%100.37K
435.24%133.16K
-Change in payables and accrued expense
104.48%45.45K
-356.22%-567.11K
507.17%2.58M
848.13%3.13M
-43.02%237.2K
45.12%-1.01M
-81.80%221.34K
-849.04%-632.95K
-140.94%-418.64K
38.83%416.26K
-Change in other current assets
110.05%8.05K
234.19%338.79K
-696.54%-329.4K
-537.39%-241.52K
50.64%-109.19K
-198.01%-80.08K
-27.32%101.38K
146.66%55.22K
-19.90%55.22K
19.37%-221.19K
-Change in other current liabilities
78.32%-19.41K
-24.53%-57.89K
-628.34%-271.5K
-137.63%-79.42K
13.25%-56.07K
-201.24%-89.53K
28.86%-46.48K
138.45%51.39K
295.51%211.08K
-5,299.36%-64.63K
-Change in other working capital
----
112.45%15.12K
105.85%21.31K
--229.29K
---80.4K
---6.12K
---121.47K
---364.15K
----
----
Cash from discontinued investing activities
Operating cash flow
32.57%-1.57M
-19.25%-2.85M
-1.10%-9.68M
24.93%-2.21M
-12.62%-2.76M
18.97%-2.32M
-81.98%-2.39M
-29.74%-9.57M
-403.82%-2.94M
2.85%-2.45M
Investing cash flow
Cash flow from continuing investing activities
-214.17%-28.07K
-70.4K
-4.70%-231.84K
-24.63%-208.52K
-663.90%-14.39K
-8.94K
0
68.10%-221.43K
7.95%-167.31K
-98.53%2.55K
Net PPE purchase and sale
-663.56%-68.23K
---70.4K
-4.70%-231.84K
-24.63%-208.52K
-663.90%-14.39K
---8.94K
--0
56.16%-221.43K
---167.31K
476.25%2.55K
Net business purchase and sale
----
----
----
----
----
----
----
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
-214.17%-28.07K
---70.4K
-4.70%-231.84K
-24.63%-208.52K
-663.90%-14.39K
---8.94K
--0
68.10%-221.43K
7.95%-167.31K
-98.53%2.55K
Financing cash flow
Cash flow from continuing financing activities
6.79%674.65K
8,282.01%3.56M
-68.42%4.6M
11,230.64%602K
-69.16%3.32M
-83.31%631.74K
42.45K
914.44%14.56M
-88.48%5.31K
526.97%10.77M
Net common stock issuance
6.79%674.65K
550.62%224.53K
-64.43%4.59M
--602K
-71.27%3.32M
-52.94%631.74K
--34.51K
405.15%12.9M
--0
352.60%11.56M
Net preferred stock issuance
----
----
----
----
----
----
----
--0
--0
---3.04M
Proceeds from stock option exercised by employees
--0
41,890.57%3.33M
-99.52%7.94K
--0
--0
--0
--7.94K
--1.66M
--5.31K
--1.65M
Cash from discontinued financing activities
Financing cash flow
6.79%674.65K
8,282.01%3.56M
-68.42%4.6M
11,230.64%602K
-69.16%3.32M
-83.31%631.74K
--42.45K
914.44%14.56M
-88.48%5.31K
526.97%10.77M
Net cash flow
Beginning cash position
-58.39%1.66M
-83.82%1.02M
310.09%6.3M
-70.13%2.81M
100.38%2.24M
2,040.24%3.99M
310.09%6.3M
-81.34%1.54M
312.07%9.4M
-61.57%1.12M
Current changes in cash
45.89%-920.94K
127.33%640.94K
-211.41%-5.31M
41.52%-1.82M
-93.37%551.84K
-297.82%-1.7M
-78.74%-2.34M
171.84%4.77M
-331.40%-3.11M
1,427.71%8.33M
Effect of exchange rate changes
102.66%1.2K
-102.47%-743
3,941.16%27.16K
132.63%29.27K
128.06%13.06K
-162.65%-45.28K
177.16%30.1K
98.91%-707
153.96%12.58K
-1,031.70%-46.55K
End cash Position
-66.98%740.37K
-58.39%1.66M
-83.82%1.02M
-83.82%1.02M
-70.13%2.81M
100.38%2.24M
2,040.24%3.99M
310.09%6.3M
310.09%6.3M
312.07%9.4M
Free cash flow
29.91%-1.64M
-22.20%-2.92M
-1.19%-9.91M
22.27%-2.42M
-13.33%-2.77M
20.24%-2.33M
-81.98%-2.39M
-24.24%-9.79M
-432.45%-3.11M
2.98%-2.44M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.57%-1.57M-19.25%-2.85M-1.10%-9.68M24.93%-2.21M-12.62%-2.76M18.97%-2.32M-81.98%-2.39M-29.74%-9.57M-403.82%-2.94M2.85%-2.45M
Net income from continuing operations -19.05%-2.69M-11.14%-2.99M-4.06%-10.6M-10.99%-3.1M14.60%-2.55M-14.19%-2.26M-10.79%-2.69M4.44%-10.19M-4.64%-2.8M52.98%-2.99M
Operating gains losses -----------------------------88.02%1.18K--------
Depreciation and amortization -8.37%281.9K0.09%303.38K0.05%1.21M6.43%306.17K-9.37%296.83K5.97%307.64K-1.45%303.11K25.48%1.21M69.15%287.69K-17.81%327.53K
Other non cash items -77.38%11.6K224.02%147.84K0.52%-24.05K-32.24%49.67K83.32%-5.79K138.35%51.28K-267.99%-119.21K89.12%-24.18K175.46%73.3K-268.36%-34.73K
Change In working capital 267.92%736.95K-636.17%-576.91K-2.69%-720.78K157.38%304.21K-1,827.58%-507.75K56.40%-438.87K-109.73%-78.37K-989.45%-701.93K-125.99%-530.18K108.38%29.39K
-Change in receivables 16.22%680.06K-15.08%-312.86K-20,620.37%-2.86M-2,341.33%-2.78M-177.48%-389.51K-12.95%585.15K37.01%-271.88K-102.33%-13.81K-110.25%-114.05K-13.15%-140.37K
-Change in inventory 1.13%37.93K-81.84%7.04K-29.67%142.32K-51.90%48.27K-86.64%17.79K71.46%37.51K173.06%38.75K158.59%202.37K137.10%100.37K435.24%133.16K
-Change in payables and accrued expense 104.48%45.45K-356.22%-567.11K507.17%2.58M848.13%3.13M-43.02%237.2K45.12%-1.01M-81.80%221.34K-849.04%-632.95K-140.94%-418.64K38.83%416.26K
-Change in other current assets 110.05%8.05K234.19%338.79K-696.54%-329.4K-537.39%-241.52K50.64%-109.19K-198.01%-80.08K-27.32%101.38K146.66%55.22K-19.90%55.22K19.37%-221.19K
-Change in other current liabilities 78.32%-19.41K-24.53%-57.89K-628.34%-271.5K-137.63%-79.42K13.25%-56.07K-201.24%-89.53K28.86%-46.48K138.45%51.39K295.51%211.08K-5,299.36%-64.63K
-Change in other working capital ----112.45%15.12K105.85%21.31K--229.29K---80.4K---6.12K---121.47K---364.15K--------
Cash from discontinued investing activities
Operating cash flow 32.57%-1.57M-19.25%-2.85M-1.10%-9.68M24.93%-2.21M-12.62%-2.76M18.97%-2.32M-81.98%-2.39M-29.74%-9.57M-403.82%-2.94M2.85%-2.45M
Investing cash flow
Cash flow from continuing investing activities -214.17%-28.07K-70.4K-4.70%-231.84K-24.63%-208.52K-663.90%-14.39K-8.94K068.10%-221.43K7.95%-167.31K-98.53%2.55K
Net PPE purchase and sale -663.56%-68.23K---70.4K-4.70%-231.84K-24.63%-208.52K-663.90%-14.39K---8.94K--056.16%-221.43K---167.31K476.25%2.55K
Net business purchase and sale ------------------------------0--0----
Cash from discontinued investing activities
Investing cash flow -214.17%-28.07K---70.4K-4.70%-231.84K-24.63%-208.52K-663.90%-14.39K---8.94K--068.10%-221.43K7.95%-167.31K-98.53%2.55K
Financing cash flow
Cash flow from continuing financing activities 6.79%674.65K8,282.01%3.56M-68.42%4.6M11,230.64%602K-69.16%3.32M-83.31%631.74K42.45K914.44%14.56M-88.48%5.31K526.97%10.77M
Net common stock issuance 6.79%674.65K550.62%224.53K-64.43%4.59M--602K-71.27%3.32M-52.94%631.74K--34.51K405.15%12.9M--0352.60%11.56M
Net preferred stock issuance ------------------------------0--0---3.04M
Proceeds from stock option exercised by employees --041,890.57%3.33M-99.52%7.94K--0--0--0--7.94K--1.66M--5.31K--1.65M
Cash from discontinued financing activities
Financing cash flow 6.79%674.65K8,282.01%3.56M-68.42%4.6M11,230.64%602K-69.16%3.32M-83.31%631.74K--42.45K914.44%14.56M-88.48%5.31K526.97%10.77M
Net cash flow
Beginning cash position -58.39%1.66M-83.82%1.02M310.09%6.3M-70.13%2.81M100.38%2.24M2,040.24%3.99M310.09%6.3M-81.34%1.54M312.07%9.4M-61.57%1.12M
Current changes in cash 45.89%-920.94K127.33%640.94K-211.41%-5.31M41.52%-1.82M-93.37%551.84K-297.82%-1.7M-78.74%-2.34M171.84%4.77M-331.40%-3.11M1,427.71%8.33M
Effect of exchange rate changes 102.66%1.2K-102.47%-7433,941.16%27.16K132.63%29.27K128.06%13.06K-162.65%-45.28K177.16%30.1K98.91%-707153.96%12.58K-1,031.70%-46.55K
End cash Position -66.98%740.37K-58.39%1.66M-83.82%1.02M-83.82%1.02M-70.13%2.81M100.38%2.24M2,040.24%3.99M310.09%6.3M310.09%6.3M312.07%9.4M
Free cash flow 29.91%-1.64M-22.20%-2.92M-1.19%-9.91M22.27%-2.42M-13.33%-2.77M20.24%-2.33M-81.98%-2.39M-24.24%-9.79M-432.45%-3.11M2.98%-2.44M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More